All News

She will spearhead FMI's new pharmacy public affairs program, launched this year to strengthen industry advocacy on federal policy.

The American Thoracic Society has issued a checklist for parents to prevent asthma exacerbations and hospitalization in children as they head back to school.

Covering Kids and Families has issued a back-to-school campaign that includes thousands of activities, including health and enrollment fairs.

Former NACDS president and CEO Craig Fuller has joined the board of PharmMD.

Former NACDS president and CEO Craig Fuller has joined the board of PharmMD.

Ferring Pharmaceuticals commissioned a report on ways osteoarthritis costs are being managed.

Biopure Corp. has drafted a protocol for patients with life-threatening anemia for whom blood transfusion is not feasible to obtain its investigational product Hemopure (HBOC-201) on a compassionate-use basis.

U.S. Senator supports NACDS efforts to reduce burdensome Medication Guide (MedGuide) requirements for a growing number of prescriptions.

Baxter International is starting a program next year to provide continued access for patients relying on Gammagard Liquid and Gammagard S/D immune globulin intravenous-Human.

NACDS president and CEO Steven Anderson praised endorsement letters the U.S. Chamber of Commerce has written to Congress, noting that they are an indication that the damaging Medicaid prescription drug reimbursement rule is a top-tier issue that requires a Congressional response.

Risperidone has been approved by the FDA for use in children and adolescents aged 10 to 17.

Officials and activists from the Service Employees International Union and the United Food & Commercial Workers recently demonstrated their opposition to Rite Aid's pending acquisition of the Eckerd and Brooks drugstores.

One of the site?s features is a diabetes forum that gives the public a venue to communicate their problems, seek assistance, and help others.

New research published in the Sept. 1 issue of Blood involving the use of genetic testing to predict a therapeutic warfarin dose has led to the development of a new dosing model for the drug.

Confidence Inc. is recalling one lot of Metabolism Apple Cider Vinegar brand dietary supplement capsules because the product contains the undeclared drug ingredient sibutramine.

Looking for discounts in specialty drugs? If so, consider Armada Health Care.

CMS has come out with a final rule that says it will not pay hospitals if Medicare patients catch a hospital-acquired infection.

The Phi Delta Chi Pharmacy Fraternity has promised to raise $200,000 over the next four years for St. Jude Children's Research Hospital.

Though they are efficient, abbreviations in health care pose a threat to patient safety.

A new law signed by Gov. Jon Corzine earlier this month requires all hospitals in the Garden State to test patients in ICUs for methicillin-resistant S. aureus.

The 2008 premium is $16 less than the $41 estimate CMS provided when the benefit was first established, and $2 less than its most recent projection.

Duane Reade Holdings and Consumer Health Services (CHS), a manager of on-site physician-centric consumer healthcare, have announced a formal affiliation agreement with Continuum Health Partners, one of the major hospital and healthcare providers in the New York City area.

Duane Reade Holdings has expanded its service offering at the Duane Reade Diabetes Resource Center.

Duane Reade and HealthTrans have announced that Duane Reade?s Performance Script Network has been awarded a two-year contract to provide prescription drug benefit services to the members of a retail, wholesale, and department store union.

Entecavir (Baraclude, Bristol-Myers Squibb) should not be used in patients coinfected by HIV and hepatitis B virus (HBV) who are not also receiving highly active antiretroviral therapy (HAART), according to an FDA-issued warning to healthcare professionals.

Alaska has become the last state to join a national network that delivers electronic prescriptions to pharmacists.

Following the death of a 13-day-old infant, the FDA has issued a public health advisory alerting mothers of the risk of taking codeine while breastfeeding.

The FDA has issued an advisory warning for parents never to give cough and cold medicines to children under the age of two unless instructed to do so by a doctor.